Skip to main navigation
Skip to Content
logo
  • About
  • Overview
  • News & Events
    • News Releases
    • Events & Presentations
  • Financial Reports
    • Annual Reports
    • Quarterly & Other Reports
    • SEC Filings
  • Stock Info
    • Stock Quote and Chart
    • Historic Stock Lookup
    • Investment Calculator
  • Analyst Coverage
  • Corporate Governance
    • Documents and Charters
    • Our Team
    • Committee Composition
  • Investor Resources
    • Email Alerts
    • Contact Us

News Releases

News Releases

Keyword Search

May-03-2021
Oncternal Therapeutics Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Apr-29-2021
Oncternal Therapeutics to Report First Quarter 2021 Financial Results and Provide Business Update
Apr-28-2021
Oncternal Therapeutics Announces Presentation of Two Abstracts at ASCO 2021 Virtual Meeting
Apr-12-2021
Oncternal Therapeutics Announces Appointment of Chase Leavitt as General Counsel
Apr-12-2021
Oncternal Therapeutics Announces Presentation of Three Posters at AACR 2021 Virtual Meeting
Mar-18-2021
Oncternal Therapeutics Reports Granting of an Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
Mar-11-2021
Oncternal Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2020 Financial Results
Mar-04-2021
Oncternal Therapeutics to Report Fourth Quarter 2020 Financial Results and Provide Business Update
Feb-24-2021
Oncternal Therapeutics to Participate in March Investor Conferences
Feb-22-2021
Oncternal Therapeutics Reports Granting of an Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

Pagination

  • First page « first
  • Previous page ‹ previous
  • …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Current page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • …
  • Next page next ›
  • Last page last »
Print
RSS Feeds
Email Alerts
Contact IR
Search
  • © 2023 Oncternal Therapeutics, Inc. All rights reserved.